USITC Opens Section 337 Probe Into Medical Imaging Devices
Washington, D.C. | January 29, 2026 — The U.S. International Trade Commission (USITC) has formally instituted a Section 337...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Washington, D.C. | January 29, 2026 — The U.S. International Trade Commission (USITC) has formally instituted a Section 337...
BAGSVAERD, DENMARK | December 31, 2025 — Novo Nordisk announced that China’s Supreme People’s Court has upheld the validity...
SALT LAKE CITY, December 29, 2025 — Co-Diagnostics announced that the Australian Patent Office has granted a key patent...
SYDNEY, Australia, December 17, 2025 — Envoy Medical, Inc. has been granted a new Australian patent for its innovative...
London, UK – November 3, 2025 Actimed Therapeutics Ltd, a UK-based clinical-stage specialty pharmaceutical company, has announced the grant...
